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Two cases of Burkitt’s lymphoma masquerading as appendicitis are reported herein. The diagnoses were made
post-operatively from the appendix specimen in one case and from an ileocecal resection specimen for cecal fistula
complicating an appendicectomy in the second case. These cases highlight the importance of routine histological
examination of appendicectomy specimens.
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Burkitt’s lymphoma is an unusual variant (5%) of malig-
nant (B-cell) non-Hodgkin’s lymphoma, which was first
described between 1958 and 1962 in children in sub-
Saharan Africa [1]. Over half of these patients presented
with jaw tumours, but it was soon realised that other or-
gans, including distal ileum, caecum, ovaries, kidney, or
the breast, were often involved and that the initial pre-
sentations were variable. Non-Hodgkin’s lymphoma is the
most common malignant tumour of the bowel in children
older than 5 years but Burkitt’s lymphoma presenting as
appendicitis is rare [2]. Untreated cases run a rapid down-
hill course and die with wide-spread metastases to the
liver, kidneys, and other organs [3].
The epidemiological and laboratory findings suggest
that that the combination of recurrent P. falciparum
malaria and Epstein-Barr virus (EBV) infection very early
in childhood cause B cell hyperplasia which is an es-
sential component of lymphomagenesis [4,5]. A sporadic
form of Burkitt’s lymphoma occurs elsewhere in the world
and has only a 5 to 15% degree of association with EBV.
A third form, human immunodeficiency virus (HIV)-
associated Burkitt’s lymphoma is associated with EBV
in approximately 40% of cases [4,6]. If suspicious of intra-
abdominal Burkitt’s lymphoma especially in an endemic
area, pre-operative imaging with ultrasonography in ex-
pert hands or computed tomography (CT) is effective at* Correspondence: elroypat@yahoo.co.uk
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tological examination of the appendix specimen following
appendicectomy for an apparent appendicitis is mandatory
as it may disclose an ileocecal Burkitt’s lymphoma.
Case presentation
Case 1 presentation
A 13-year-old female was admitted electively for investi-
gation of a long history (3 years) of right iliac fossa pain.
This was a recurring dull and aching pain that had not
responded to analgesia and antibiotics for suspected re-
lapsing or ‘chronic’ appendicitis. She had no anorexia or
weight loss. She had no constitutional symptoms, such
as lethargy, fever, or night sweats, and had no altered
bowel habits or urinary symptoms. On examination she
appeared clinically well. The abdomen was soft but ten-
der on deep palpation of the right iliac fossa. Thefull blood
count and urinalysis were normal. Ultrasound examina-
tion suggested an appendicitis. At operation, a Lanz inci-
sion was made in the right iliac fossa. There was some
free fluid in the peritoneal cavity but the appendix did not
appear inflamed. It simply had a yellowish tinge. There
was terminal ileal lymphadenopathy. The histology of the
appendix specimen revealed a B-cell non-Hodgkin’s lym-
phoma consistent with Burkitt’s lymphoma (Figure 1). She
made full postoperative recovery and underwent a 6-
month course of chemotherapy (i/v cyclophosphamide
and vincristine together with oral prednisolone) having
tested as HIV seronegative prior to its commencement.
Eight years later, she is very well and has graduated as an
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Figure 1 The Starry-sky pattern of Burkitt’s lymphoma. The
tumour cells of B lymphoblasts which are large rounded or indented
nucleus and 3 or 4 nucleoli with thin layer of basophilic cytoplasm
are closely apposed to each other forming a dark blue background
(the ‘sky’). The surrounding macrophages with abundant pale foamy
cytoplasm scattered among the tumour cells (the stars).
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An 18-year-old female was referred as an emergency
with a cecal fistula complicating an appendicectomy per-
formedtwo weeks previously. The indication for the ap-
pendicectomy was for an apparent appendicitis following
a vague history of right iliac fossa pain. An attempted
closure of the fistula failed. On examination, she was
clinically dehydrated and exhausted but not toxic. She
had no constitutional symptoms and the vital signs were
normal. There was a persistent and high output (greater
than 1 L/24 h) intestinal fistula in the right iliac fossa
consistent with a cecal fistula. She was resuscitated with
appropriate fluids and because of the persistent output
from the high-pressure caecum a decision was made for
surgical correction two days later. At laparotomy, there
was a cecal fistula from the dehisced appendix stump.
Apart for significant ileocecal lymphadenopathy the
rest of the abdomen appeared normal. Following ex-
tensive lavage of the operation field with saline solu-
tion, an ileocecal resection with end-to-end anastomosis
of the ileum and ascending colon was performed. The
histology of the operative specimen confirmed a B-cell
non-Hodgkin’s lymphoma consistent with Burkitt’s lymph-
oma. She had a stormy post-operative recovery and when
fully recovered underwent a 6-month course of chemo-
therapy (i/v cyclophosphamide and vincristine together
with oral prednisolone) having tested as HIV seronegative
prior to its commencement. Nine years later she is well
with no evidence of metastases but with fertility problems.
Discussion
Burkitt’s lymphoma is a highly aggressive B-cell non-
Hodgkin’s lymphoma and is the fastest growing human
tumour [9,10]. This EBV-associated lymphoma was oneof the first tumours shown to have a chromosomal trans-
location (chromosome 14) that activates an oncogene
(c-MYC) [4]. The incidence is very high with an aggressive
clinical course in immunosuppressed patients in non-
endemic areas especially when associated with HIV infec-
tion. They were all positive for EBV in a case series [11].
Clinically, Burkitt’s lymphoma patients do not usually ex-
hibit the B-symptoms (fever, night sweats, and weight loss)
characteristic of early non-Hodgkin’s lymphoma. This is
because the transformation of these cells compromises
host defence and evolves mechanisms to escape immune
surveillance [12]. Patients with a rapidly growing extrano-
dal intra-abdominal Burkitt's tumour present with symp-
toms of bowel obstruction, intussusception, or appendicitis
[13]. Both cases reported here gave an atypical history
for appendicitis especially regarding the duration of the
abdominal pain [14]. The differential diagnosis would
include a true relapsing or chronic appendicitis which
are rare and often difficult to diagnose as the symptoms
may be atypical and short-lived [15]. Because of re-
source limitations, the diagnoses of Burkitt’s lymphoma
in these cases were post-operative. In the first case the
diagnosis was made from the histological examination
of the appendix specimen. In the second case, where an
ileocecal Burkitt’s lymphoma masqueraded as an appen-
dicitis, the diagnosis was made only following the histo-
logical examination of the resected ileocecal specimen.
The demonstration of a malignant appendix by pre-
operative imaging with ultrasonography or CT would
influence the surgical approach for pathological staging
of the disease [16]. A bone marrow biopsy may show
infiltration by Burkitt’s lymphoma (dissemination) [17].
The diagnosis may also be established by laparoscopy
following which the appendix can be removed [18]. Due
to Burkitt’s lymphoma’s rapid doubling time, aggressive
chemotherapy is required to control its spread and growth
[19,20]. Paradoxically it is the high grade non-Hodgkin’s
lymphoma that may be curable and consequently should be
treated with high-dose multidrug regimens in addition to
malaria prophylaxis in Burkitt’s lymphoma [20]. Intensive
chemotherapy with CODOX-M/IVAC (cyclophosphamide,
vincristine, doxorubicin, and high dose methotrexate,
alternating with ifosfamide, etoposide, and cytarabine)
is the definitive treatment [17,19,20]. The improved
chemotherapy and support care available are due to the
better understanding of the biology of the disease
[12,17]. The outcome has improved and is now excel-
lent in children; the current 5-year survival for ad-
vanced (disseminated) Burkitt’s lymphoma in children
and adolescents has increased by 2- to3-fold in the past
3 decades to 85% to 90% following less than 6 months
of intensive chemotherapy [9,10].
The two patients in the case report were tested as be-
ing HIV seronegative prior to commencing the above
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in these patients may perhaps not have been achieved if
they were HIV seropositive in terms of disease pro-
gression and response to chemotherapy [11,21]. Adju-
vant CD20-directed monoclonal antibody therapy with
rituximab shows promise for improving outcome and
reducing the toxic effects of cytotoxic chemotherapy.
Rituximab decreased the recurrence rate and showed
a trend in favour of improvement in overall survival
or disease-free survival [22]. CODOX-M/IVAC with ritux-
imab is a highly effective regime for the treatment of adult
Burkitt’s lymphoma which usually has a poor prognosis
[23]. Current risk factors in the prognosis of children and
adolescent Burkitt’s are elevated lactate dehydrogenase
greater than twice the upper limit, bone marrow and cen-
tral nervous system involvement, poor response to cyto-
reduction therapy, and poor risk cytogenetics [3,9,10].
Radiotherapy is used only in emergencies such as superior
vena cava syndrome, acute neurological impairment, or in
patients with relapse [1,3,9,10]. Further investigations
including CT and PET scanning for response evaluation
in these patients would be possible in a resourced area.
There is a need for more clinical data on the use of PET
and magnetic resonance technology in the determina-
tion of response evaluation of children with Burkitt’s
lymphoma [3,16].
Conclusions
Although Burkitt’s lymphoma presenting as appendicitis
is rare, it should be considered an important differential
diagnosis in children and adolescents from sub-Saharan
Africa with atypical right iliac fossa pain. The reported
cases demonstrate the importance of histologically exa-
mining appendicectomy specimens especially in patients
with atypical presentations of appendicitis. The appendix,
being a lymphoid organ, may be the most appropriate
and accessible extranodal tissue for diagnosing intra-
abdominal Burkitt’s lymphoma or other diseases. Under-
standing the underlying biology of Burkitt’s lymphoma
would lead to strategies for prevention and approaches to
reduce acute and chronic toxicities from current cytotoxic
treatment.
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